After treatment with thiazolidinediones, adiponectin values increase in NASH as a sign of improvement of hepatic steatosis, necroinflammation and, most importantly, fibrosis [63]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.